Literature DB >> 1432030

Effect of intracarotid infusion of etoposide with angiotensin II-induced hypertension on the blood-brain barrier and the brain tissue.

H Ogasawara1, K Kiya, K Kurisu, T Hotta, T Mikami, K Sugiyama, T Nakahara, T Uozumi.   

Abstract

This study investigated the effects of the intracarotid infusion of etoposide in combination with angiotensin II (AT II)-induced hypertension on the blood-brain barrier (BBB) and brain tissue in rats. Eighty rats were divided into five groups: Group 1, intravenous infusion of AT II to increase arterial blood pressure; Group 2, intracarotid infusion of etoposide at 22.5 mg/m2 for 10 minutes; Group 3, intracarotid infusion of etoposide at 75.0 mg/m2 for 10 minutes; Group 4, intracarotid infusion of etoposide at 75.0 mg/m2 for 20 minutes; Group 5, intracarotid infusion of etoposide at 75.0 mg/m2 for 10 minutes with AT II-induced hypertension. Evans blue staining of the brain was used as a monitor of BBB disruption. Mean arterial blood pressure over the experimental period in Group 1 increased from 86.3 +/- 1.3 mmHg (mean +/- SEM) to 139.0 +/- 2.4 mmHg, and Group 5 from 85.9 +/- 1.8 mmHg to 137.3 +/- 2.4 mmHg. None of the animals in Group 1 and 2 showed any obvious neurological change, while all the animals in Group 3, 4 and 5 exhibited diminished activity as their sole neurological change throughout the course of the experiment. Slight evidence of BBB disruption was seen in only 25% of the animals in Group 1. Significant BBB disruption was found in the animals in Group 2, 3, 4 and 5. No histological change was observed in any animal in Group 1 and 2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1432030     DOI: 10.1007/bf00172760

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  14 in total

1.  Effect of alcohol injections on the blood-brain barrier.

Authors:  J C LEE
Journal:  Q J Stud Alcohol       Date:  1962-03

2.  Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4'-demethyl epipodophyllotoxin thenylidene-beta-D-glucoside and 4'-demethyl epipodophyllotoxin ethylidene-beta-D-glucoside, in the L1210 leukemia cell.

Authors:  L M Allen
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

3.  Osmotic opening of the blood-brain barrier and local cerebral glucose utilization.

Authors:  H M Pappius; H E Savaki; C Fieschi; S I Rapoport; L Sokoloff
Journal:  Ann Neurol       Date:  1979-03       Impact factor: 10.422

4.  Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.

Authors:  M K Spigelman; R A Zappulla; J A Strauchen; E J Feuer; J Johnson; S J Goldsmith; L I Malis; J F Holland
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

5.  Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies.

Authors:  E A Neuwelt; M Glasberg; E Frenkel; P Barnett
Journal:  Ann Neurol       Date:  1983-09       Impact factor: 10.422

6.  Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma.

Authors:  R S Leff; J M Thompson; M B Daly; D B Johnson; E A Harden; R J Mercier; G L Messerschmidt
Journal:  Cancer       Date:  1988-07-01       Impact factor: 6.860

7.  Neurotoxicity after intracarotid 1,3-bis(2-chloroethyl)-1-nitrosourea administration in the rat: hemodynamic changes studied by double-tracer autoradiography.

Authors:  S Nagahiro; Y L Yamamoto; M Diksic; S Mitsuka; S Sugimoto; W Feindel
Journal:  Neurosurgery       Date:  1991-07       Impact factor: 4.654

8.  Heterogeneity of brain blood flow and permeability during acute hypertension.

Authors:  G L Baumbach; D D Heistad
Journal:  Am J Physiol       Date:  1985-09

9.  A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II.

Authors:  M Suzuki; K Hori; I Abe; S Saito; H Sato
Journal:  J Natl Cancer Inst       Date:  1981-09       Impact factor: 13.506

10.  Etoposide-induced blood-brain barrier disruption. Effect of drug compared with that of solvents.

Authors:  M K Spigelman; R A Zappulla; J Johnson; S J Goldsmith; L I Malis; J F Holland
Journal:  J Neurosurg       Date:  1984-10       Impact factor: 5.115

View more
  1 in total

1.  Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres.

Authors:  Delyan P Ivanov; Terry L Parker; David A Walker; Cameron Alexander; Marianne B Ashford; Paul R Gellert; Martin C Garnett
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.